Evidence map›Paper›PMID 41902951›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026

The descriptive epidemiology of gastric cancer in Afghanistan: a population-based cancer registry, 2018-2020.

Maihan Abdullah, Fatemeh Ghasemi-Kebria, Goodarz Danai, Jesse B Bump, Timothy R Rebbeck, Chihaya Koriyama, Nisar Niazi, Ikram Hashimi, Mirwais Safi, Sayed Mohammad Milad Fekrat and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maihan AbdullahTakemi Program in International Health, Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Ave, Boston, MA, 02115, USA. maihanabdullah22@gmail.com.ORCID 0000-0002-5794-6767
Fatemeh Ghasemi-KebriaGolestan Research Center of Gastroenterology and Hepatology, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran.
Goodarz DanaiDepartment of Global Health and Population, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Jesse B BumpTakemi Program in International Health, Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Ave, Boston, MA, 02115, USA.
Timothy R RebbeckDana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, MA, USA.
Chihaya KoriyamaDepartment of Epidemiology and Preventive Medicine, Graduate School of Medicine and Dental Science, Kagoshima University, Kagoshima, 890-0065, Japan.
Nisar NiaziNCD Alliance Afghanistan, Kabul, Afghanistan.
Ikram HashimiNCD Alliance Afghanistan, Kabul, Afghanistan.
Mirwais SafiIbn-e-Sina Emergency Hospital, Kabul, Afghanistan.
Sayed Mohammad Milad FekratKabul University of Medical Science, Kabul, Afghanistan.
Sabira NiyaziHayat Balkh Institute of Health Sciences, Mazar-e-Sharif, Balkh, Afghanistan.
Gholamreza RoshandelGolestan Research Center of Gastroenterology and Hepatology, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGastric cancer (GC) remains a global public health concern; however, studies on detailed epidemiological characteristics within Afghanistan are limited. This study was conducted to estimate the incidence of subtypes of GC in Afghanistan as well as in its eight regions by age and sex.

methodsWe used data from the Kabul Population-based Cancer Registry (KCR) to estimate age-standardized incidence rates (ASIRs) for cardia GC (CGC) and non-cardia GC (NCGC) in Afghanistan between 2018 and 2020. We also analyzed the ASIRs of GC in the eight regions of the country.

resultsThe ASIRs of GC in males and females combined were 4.1 (95% CI 3.9–4.3) per 100,000 person-years in 2018–2020, with a male-to-female age-standardized incidence rate ratio (ASIRR) of 2.5. The ASIR of CGC was 2.4, and that of unspecified subsites was 1.6. The ASIR of GC adenocarcinoma was 2.8, whereas that of other types was 0.68. The incidence rate was highest (age-specific incidence rate: 30.2) in patients aged 70–74 years. Among the eight regions of Afghanistan, the GC incidence rate was highest in the Central region (ASIR: 3.8 per 100,000 person-years), followed by the Southeast region (ASIR: 3.5), whereas it was lowest in the Southwest region (ASIR: 0.38).

conclusionThis population-based cancer registry study reports the incidence rates of GC for the first time in Afghanistan. These findings demonstrate significant variation in GC epidemiology across Afghanistan’s demographic and geographic settings. The dominance of cardia tumors, male sex, and significant regional differences suggest the need for targeted screening and preventive strategies.

Indexed as

AdenocarcinomaStomach NeoplasmsAdolescentAdultAfghanistanAgedAged, 80 and overChildChild, PreschoolFemaleHumansIncidenceMaleMiddle AgedRegistriesYoung AdultAnatomic subsites of stomach neoplasmsGastric cancer in AfghanistanHistological subtypes of gastric cancerIncidence of stomach cancer in Afghanistan

Identifiers

PMID41902951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.